THE HOLBROOK AND SHOTLEY PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: D83020 | IPSWICH, IP9 2QS
Showing results 501-550 of 597
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 18 | 540 | £990 | +122.7% ▲ | |
| Reboxetine | 17 | 376 | £105 | +10.4% ▲ |
| Dexamfetamine sulfate | 17 | 515 | £498 | -52.7% ▼ |
| Somatropin | 17 | 53 | £16.5K | +20.0% ▲ |
| Potassium chloride | 17 | 360 | £35 | -9.1% ▼ |
| Budesonide | 17 | 17 | £123 | +9.3% ▲ |
| Menthol | 17 | 7,300 | £247 | -39.6% ▼ |
| Terbinafine hydrochloride | 17 | 345 | £68 | -54.2% ▼ |
| Chlorhexidine gluconate | 17 | 7,000 | £129 | -42.4% ▼ |
| Co-tenidone (Atenolol/chlortalidone) | 16 | 434 | £61 | -23.3% ▼ |
| Enoxaparin | 16 | 174 | £695 | -21.9% ▼ |
| Formoterol/glycopyrronium/budesonide | 16 | 16 | £633 | -73.4% ▼ |
| Amantadine hydrochloride | 16 | 812 | £191 | -42.6% ▼ |
| Sirolimus | 16 | 480 | £1.2K | +35.3% ▲ |
| Nabumetone | 16 | 1,182 | £365 | +15.1% ▲ |
| Other eye tear/lubricant/astringent preparations | 16 | 1,600 | £113 | +46.3% ▲ |
| 16 | 150 | £969 | -59.3% ▼ | |
| 16 | 2,281 | £3.4K | -9.3% ▼ | |
| 16 | 2,560 | £129 | -84.2% ▼ | |
| Levodopa/carbidopa/entacapone | 15 | 2,562 | £787 | -46.4% ▼ |
| Erythromycin ethylsuccinate | 15 | 4,200 | £317 | -35.8% ▼ |
| Prednisolone sodium phosphate | 15 | 1,020 | £616 | +17.6% ▲ |
| Timolol and brimonidine | 15 | 75 | £133 | +6.9% ▲ |
| 15 | 2,100 | £71 | -82.4% ▼ | |
| 15 | 1,170 | £2.0K | -29.1% ▼ | |
| 15 | 1,160 | £248 | -49.0% ▼ | |
| 15 | 520 | £959 | +71.2% ▲ | |
| Glycerol | 14 | 148 | £26 | -60.1% ▼ |
| Sennosides | 14 | 3,208 | £65 | -54.7% ▼ |
| Lidocaine hydrochloride | 14 | 256 | £47 | +205.2% ▲ |
| Methyldopa | 14 | 1,568 | £372 | -17.8% ▼ |
| Valsartan with diuretic | 14 | 392 | £275 | +5.7% ▲ |
| Desloratadine | 14 | 420 | £37 | -51.5% ▼ |
| Trimipramine maleate | 14 | 1,568 | £5.4K | -12.1% ▼ |
| Oestrogens conjugated with progestogen | 14 | 1,176 | £425 | +96.5% ▲ |
| Triptorelin embonate | 14 | 14 | £5.2K | +40.6% ▲ |
| Ketotifen fumarate | 14 | 70 | £97 | +50.5% ▲ |
| Xylometazoline hydrochloride | 14 | 270 | £64 | +143.8% ▲ |
| 14 | 200 | £306 | -23.6% ▼ | |
| Olmesartan medoxomil/hydrochlorothiazide | 13 | 364 | £202 | +31.1% ▲ |
| Salmeterol | 13 | 13 | £406 | -45.9% ▼ |
| Mometasone/glycopyrronium/indacaterol | 13 | 390 | £514 | -14.2% ▼ |
| Dosulepin hydrochloride | 13 | 728 | £175 | -77.0% ▼ |
| Doxepin | 13 | 728 | £1.7K | +0.0% vs avg |
| Repaglinide | 13 | 1,170 | £122 | -46.2% ▼ |
| Darifenacin hydrobromide | 13 | 364 | £306 | -60.1% ▼ |
| Other compound vitamin/mineral formulation preparations | 13 | 364 | £15 | -59.5% ▼ |
| Gentamicin sulfate | 13 | 130 | £231 | +136.6% ▲ |
| Benzalkonium chloride | 13 | 5,600 | £120 | -3.0% ▼ |
| Azelaic acid | 13 | 390 | £63 | -45.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.